Quick Answer
Sana Biotechnology, Inc. reported Net Income of -$244.17 million for fiscal year 2025.
Sana Biotechnology, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$244.17M | +8.5% |
| 2024 | -$266.76M | +5.8% |
| 2023 | -$283.25M | -5.1% |
| 2022 | -$269.48M | +24.3% |
| 2021 | -$355.93M | -24.8% |
| 2020 | -$285.31M | -118.2% |
| 2019 | -$130.78M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$42.15M | +29.7% | +55.1% |
| June 30, 2025 | -$93.80M | -86.5% | -89.9% |
| March 31, 2025 | -$49.39M | +54.0% | +17.6% |
| September 30, 2024 | -$59.92M | -6189.8% | -19.2% |
| June 30, 2024 | -$50.29M | +55.9% | +53.2% |
| March 31, 2024 | -$107.47M | -30.9% | -11022.3% |
| September 30, 2023 | $984.0K | +101.2% | +100.9% |
| June 30, 2023 | -$114.00M | -57.3% | -38.8% |
- Sana Biotechnology, Inc. showed an increase of +8.5% in Net Income compared to the prior fiscal year.
- Over the 2019–2025 period, Sana Biotechnology, Inc.’s net income has declined by 86.7% (from -$130.78 million to -$244.17 million).
- The most recent figure is from Sana Biotechnology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: